CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
The Real-World Experience of Single-Center, Retrospective Study of the Prognostic Effect of Secondary Hormone Agent on Survival in Patients With Hormone-Refractory Metastatic Prostate Cancer
Sung Han Kim, Done-Eun Lee, Ho Kyung Seo, Jinsoo Chung, Jae Young Joung
Korean J Urol Oncol. 2021;19(1):48-59.   Published online 2021 February 26    DOI: https://doi.org/10.22465/kjuo.2021.19.1.48

Excel Download

The Real-World Experience of Single-Center, Retrospective Study of the Prognostic Effect of Secondary Hormone Agent on Survival in Patients With Hormone-Refractory Metastatic Prostate Cancer
The Korean Journal of Urological Oncology. 2021;19(1):48-59   Crossref logo
Link1 Link2 Link3

Prognostic factors for survival of patients with bidimensionally measurable metastatic hormone-refractory prostatic cancer treated with single-agent chemotherapy
Cancer. 1992;70(12):2870-2878   Crossref logo
Link1 Link2

Chemotherapy in frail elderly patients with hormone-refractory prostate cancer: A “real world” experience
Prostate International. 2016;4(1):15-19   Crossref logo
Link1 Link2

Leukoerythroblastic anemia in metastatic prostate cancer. Clinical and prognostic significance in patients with hormone-refractory disease
Cancer. 1993;71(11):3594-3600   Crossref logo
Link1 Link2

Prostate-specific antigen velocity and survival for patients with hormone-refractory metastatic prostate carcinoma
Cancer. 2006;106(1):63-67   Crossref logo
Link1

Descriptive study of metastatic breast cancer patients with long-term progression-free survival during first-line hormone therapy: Experience from a single cancer center
The Breast. 2011;20:S42-S43   Crossref logo
Link1 Link2

Improved Survival Benefit of Autologous Dendritic Cell–Based Vaccine for Hormone Refractory Prostate Cancer: A Retrospective Subset Analysis of the D9901 Trial
Clinical Prostate Cancer. 2004;2(4):212   Crossref logo
Link1 Link2

1159. A Phase I/II Study of High Dose Allogeneic GM-CSF Gene-Transduced Prostate Cancer Cell Line Vaccine in Patients with Metastatic Hormone-Refractory Prostate Cancer
Molecular Therapy. 2003;7(5):S447   Crossref logo
Link1 Link2

Updated: 223Ra-chloride therapy in men with hormone-refractory prostate cancer and skeletal metastases: Real-world experience
Tumori Journal. 2019;105(3):271-271   Crossref logo
Link1 Link2 Link3

Phase II trial of single-agent weekly docetaxel in hormone-refractory, symptomatic, metastatic carcinoma of the prostate
Seminars in Oncology. 2001;28:8-15   Crossref logo
Link1 Link2